Revenue Cycle Advisory for Gastroenterology.

Why Revenue Cycle Management Is Different for Gastroenterology

Gastroenterology groups balance high-volume screening and diagnostic endoscopies (colonoscopy, EGD, ERCP, capsule endoscopy), pathology lab integration, anesthesia/CRNA coordination, and biologic infusion therapy for IBD (Crohn’s and ulcerative colitis).

GI billing hinges on screening-to-diagnostic colonoscopy conversion rules (Modifiers PT for Medicare and 33 for commercial ACA preventive plans), multiple-technique polyp removal bundling (45380, 45384, 45385 with Modifier 59/XS), and biologic infusion J-codes.

• GI billing hinges on screening-to-diagnostic colonoscopy conversion rules (Modifiers PT for Medicare and 33 for commercial ACA preventive plans), multiple-technique polyp removal bundling (45380, 45384, 45385 with Modifier 59/XS), and biologic infusion J-codes.
• Alignment with CMS National Correct Coding Initiative (NCCI) PTP edits, MUE unit caps, and regional MAC Local Coverage Determinations (LCDs)
• Pre-bill verification of prior authorization numbers, rendering provider credentials, and site-of-service differentials
• Contractual fee-schedule modeling to catch commercial and Medicare Advantage underpayments at 835ERA posting

Prior Authorization, Medical Necessity & Denial Patterns in Gastroenterology

Prior authorization is heavily enforced on capsule endoscopy, advanced motility studies, biologic infusions (infliximab, vedolizumab, ustekinumab), and repeat endoscopies within payer frequency windows.

Common GI leakage includes improper patient cost-sharing or payer denials on screening colonoscopies converted to polypectomy (Modifiers PT/33), NCCI unbundling denials on biopsy + snare polypectomy, and uncaptured ASC/pathology split components.

• Front-end eligibility and benefit verification tied directly to scheduled CPT/HCPCS procedure codes and site-of-service POS indicators
• Automated tracking of payer-specific prior authorization validity windows, unit thresholds, and peer-to-peer clinical escalation timelines
• Root-cause categorization of CARC 50 (medical necessity), CARC 97 (bundling/inclusive service), CARC 197 (missing precertification), and CARC 4/16 (modifier/claim data errors)
• Contractual underpayment variance auditing against Medicare Physician Fee Schedule (MPFS), ASC payment rates, and commercial payer fee schedules

Important KPIs, Benchmarks & A/R Economics for Gastroenterology Groups

For gastroenterology organizations between $5M and $100M+ in net patient revenue, eliminating specialty coding friction, prior authorization write-offs, and silent payer underpayments directly improves cash velocity and operating EBITDA.

Endoscopy report writers (gMed/ModMed, Provation, EndoSoft) must map polyp location, removal technique, and bowel prep status (Modifier 52/53 for incomplete colonoscopies) directly into the PM billing system.

In-House vs. Outsourced Gastroenterology Billing: What to Evaluate in an RCM Partner

Deciding whether to run gastroenterology billing internally, operate a hybrid model, or outsource to a specialty RCM company requires looking past headline percentage fees. A billing vendor charging 4% that leaves 6% of net collectible revenue on the table through unappealed CARC 97/50 denials or unworked >90-day A/R costs far more than a disciplined internal or specialty-calibrated operation.

RCM Advisory Partners helps organizations benchmark their current operation before negotiating with vendors, and structures rigorous evaluation criteria when an external partner is warranted.

• Encounter-to-claim charge capture reconciliation across all gastroenterology service locations
• Specialty CPT, HCPCS, ICD-10-CM, and modifier accuracy audit for gastroenterology
• Prior authorization intake, medical-necessity documentation, and CARC 197/50 denial prevention
• Line-level payer allowable reconciliation and aged >90-day A/R recovery workflow review
• Verify certified coder proficiency in gastroenterology CPT/HCPCS hierarchies, NCCI bundling edits, and Medicare LCDs
• Audit true net collection yield against contracted gastroenterology fee schedules rather than blended gross adjustments
• Require transparent workqueue visibility on >60 and >90 day A/R and clinical appeal overturn rates

30/60/90-Day Gastroenterology Revenue Cycle Diagnostic & Optimization Plan

Our advisory engagements translate gastroenterology claim and remittance data into a prioritized 90-day execution roadmap:

1. 01
   Days 1–30: Specialty Claim Audit, Coding Review & Fee Schedule Reconciliation

   Audit a statistically valid sample of paid, denied, and zero-pay gastroenterology claims across top commercial and Medicare payers; benchmark CPT/modifier distribution and identify immediate underpayment and denial recovery opportunities.

2. 02
   Days 31–60: Prior Authorization, Scrubber Edit & EHR Template Remediation

   Reconfigure front-end authorization matrices, clinical documentation templates, and clearinghouse NCCI/LCD pre-bill edits to stop preventable denials before 837 submission.

3. 03
   Days 61–90: Aged A/R Recovery, Payer Escalation & Vendor SLA Governance

   Deploy structured appeal playbooks for high-value surgical, diagnostic, or infusion claims, and establish monthly KPI scorecards holding internal leads or external billing partners accountable.